Providence Sacred Heart Medical Center and Providence Medial Research Center have been selected as one of about 50 sites for a National Institutes of Health study to determine if aggressive treatment of stroke victims for high blood pressure and cholesterol-along with placing a stent to widen a narrowed artery in a patient's brain-can reduce their risk of having a second stroke.
"People who suffer an ischemic stroke, the most common kind of stroke, have a 30 percent to 50 percent chance of having another stroke," says Dr. Chris Zylak, a neurointerventional radiologist and the lead researcher for the study here. Drs. Zylak and Madeleine Geraghty, director of Sacred Heart's Primary Stroke Center, will treat study patients.
The best treatment for prevention of another stroke or TIA (transitory ischemic attack or mini stroke) in patients with narrowing of one of the arteries in the brain is uncertain. A common treatment is the use of anti-clotting medications to prevent blood clots from forming in the narrowed vessel. There are a variety of medicines used for this purpose. These medications are usually taken for the rest of a patient's life.
The SAMMPRIS trial is a study funded by The National Institutes of Health (NIH). It is being done to determine whether intracranial stenting (a device inserted in a blood vessel in the brain) combined with intensive medical therapy is better than intensive medical therapy alone for preventing stroke or death in individuals who have had a stroke or TIA caused by a narrowing in one of the arteries in the brain.
Radica Z. Alicic, MD, Sandeep A. Saha, MD, Robert A. Short, PhD, and Katherine R. Tuttle, MD
Current Hypertension Reports 2009, 11:354-362
Albuminuria has been recognized as a risk marker for both chronic kidney disease and cardiovascular disease in large observational cohorts. In addition, post hoc analyses of many large randomized trials have found a positive relationship between albuminuria and adverse renal and cardiovascular outcomes, leading some to suggest that albuminuria may be a potential therapeutic target for antihypertensive treatment. However, direct clinical evidence linking albuminuria reduction to reduction in adverse renal and cardiovascular events is scarce. (Abstract on line)
It's a simple premise, but it's the foundation of the "Start!" movement, from the American Heart Association (AHA). Research has shown that you can gain about two hours of life for every hour of regular vigorous exercise you do. You couldn't find a better two-for-one deal if you tried!
It's a good thing, too. The American workforce is becoming more and more sedentary. As a result, our waistbands are growing. So are our healthcare costs and the number of preventable illnesses.
Start! is here to stop the trend. Walking is simply the first step toward a healthier lifestyle.
So join the Start! Movement. Check out the AHA free tools on-line to motivate more Americans to Start! walking:
The Start! movement is here to motivate and encourage all Americans to take up walking and other healthy habits as part of their daily routine all year round, and to live longer, stronger, heart-healthy lives.
April 8th is National Start! Walking Day, we challenge you to join the nationwide campaign to get Americans walking! The goal of The American Heart Association is to walk a million steps and raise $1 million.
The AHA Challenge for You!
-
Start! by getting out and taking a WALK
- Then take 30 minutes to inspire your friends and family by sending them an email.
- Encorage them to take a WALK and join you in raising funds to fight our nation's No. 1 and No. 3 killers -heart disease and stroke.
- Options :
- View Article Map